20/20 Biolabs, Inc. Common Stock (AIDX) Live Share Price, Invest From India

20/20 Biolabs, Inc. Common Stock Stock Performance

as on June 3, 2026 at 6:58 am IST

Day's Low
Day's High
$0.84
Day's Price Range
$0.97
$0.90
6.67%
Downside
7.78%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.90
100.00%
Downside
-100.00%
Upside

20/20 Biolabs, Inc. Common Stock share price movements today

Previous Close: $1.03
Open: $0.94
Volume: 416.6K
Day's Low - High: $0.84 - $0.97

20/20 Biolabs, Inc. Common Stock Historical Returns

1 Month Return: -33.33 %
3 Month Return: -69.62 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

20/20 Biolabs, Inc. Common Stock Stock Fundamentals & Key Indicators

Check 20/20 Biolabs, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.2M

EPS (TTM)

-0.42

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-241.59%

20/20 Biolabs, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 20/20 Biolabs, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
20/20 Biolabs, Inc. Common Stock	NA	$9.2M	NA	NA	-279.13%	NA
Stryker Corporation	BUY	$117.0B	19.44%	35.35	13.21%	1.1199999999999999%
Edwards Lifesciences Corp	BUY	$49.8B	-5.59%	46.74	17.39%	NA
Boston Scientific Corp	BUY	$71.8B	15.31%	20.21	17.29%	NA
Medtronic PLC	BUY	$94.8B	-40.24%	20.62	13.00%	3.74%

See all

Indian Investors' Interest in 20/20 Biolabs, Inc. Common Stock Stock

Search interest for 20/20 Biolabs, Inc. Common Stock Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 4, 2026 to June 3, 2026

Change:-8% versus previous 30 day period

20/20 Biolabs, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2024	Dec 2024	Mar 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0
Operating Income	-1	-1	-1	-1	0	0	0	-1
EBITDA	-1	-1	-1	-1	-	0	-	-1
Interest Expense	0	0	-	-	0	0	0	0
Depreciation	-	-	-	0	0	-	0	0
Income Before Tax	-1	-1	-1	-1	0	0	-1	-2
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-1	-1	-1	-1	0	0	-1	-2
Net Profit Margin	-475.66%	-511.03%	-518.97%	-232.99%	-138.06%	-197.51%	-242.96%	-600.11%

20/20 Biolabs, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	0	2	9	11	1	1	2,045
Gross Profit	0	0	0	0	0	4	5	0	0	604
Operating Income	-2	-1	-1	-2	-2	1	1	-6	-5	-3,330
EBITDA	-2	-1	-1	-2	-1	2	1	-6	-5	-3,330
Interest Expense	0	-	-	-	-	0	0	0	0	156
Depreciation	-	-	-	-	-	-	-	0	0	0
Income Before Tax	-2	-1	-1	-2	-2	2	2	-6	-5	-3,738
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-2	-1	-1	-2	-2	2	2	-6	-5	-3,738
Net Profit Margin	-521.79%	-403.63%	-528.11%	-841.25%	-86.75%	21.53%	19.77%	-448.73%	-316.81%	-182.82%

20/20 Biolabs, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Dec 2024	Mar 2025	Dec 2025	Mar 2026
Net Income	-1	-1	0	-1	-2
Operating Cash Flow	-1	0	0	0	-1
Investing Cash Flow	0	-	-	-	0
Financing Cash Flow	0	0	0	0	4
Change in Cash	-1	1	0	0	3

20/20 Biolabs, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	-1	-2	-2	2	2	-6	-5	-3,738
Operating Cash Flow	-1	-1	-2	-2	-1	5	-4	-2	-1,919
Investing Cash Flow	0	0	-1	1	0	0	0	-	-
Financing Cash Flow	1	3	1	3	1	0	0	0	1,161
Change in Cash	0	2	-2	2	0	5	-4	-2	-758

Global Institutional Holdings in 20/20 Biolabs, Inc. Common Stock

Funds	Holdings
Toth Financial Advisory Corp	0%
Hanson Mcclain Inc	0%
Cresset Asset Management, LLC	2.52%
Citadel Advisors Llc	0.15%
XTX Topco Ltd	0.1%

See all

Insights on 20/20 Biolabs, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 1 month, AIDX stock has moved down by -33.3%

About 20/20 Biolabs, Inc. Common Stock

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.

Organisation	20/20 Biolabs, Inc. Common Stock
Headquarters	15810 Gaither Road, Gaithersburg, MD, United States, 20877
Industry	Medical Devices
CEO	Mr. Jonathan Cohen
E-voting on shares	Click here to vote

Key Management of 20/20 Biolabs, Inc. Common Stock

Name	Title
Mr. Jonathan Cohen	Founder, CEO, President & Director
Dr. Jiming Zhou Ph.D.	Chief Operating Officer
Dr. Michael Saul Lebowitz Ph.D.	Chief Scientific Officer
Mr. Alan B. Bergman	Chief Financial Officer
Mr. David Lees	Director of Sales
Mr. Ronald R. Baker	Chief Business Officer
Marc Gordon	Controller

FAQs

What is 20/20 Biolabs, Inc. Common Stock share price today?

20/20 Biolabs, Inc. Common Stock share price today is $0.9 as on June 3, 2026 at 1:28 am IST at the close of the market. 20/20 Biolabs, Inc. Common Stock share today touched a day high of $0.97 and a low of $0.84.

What is the 52 week high and 52 week low for 20/20 Biolabs, Inc. Common Stock share?

20/20 Biolabs, Inc. Common Stock share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. 20/20 Biolabs, Inc. Common Stock stock price today i.e. June 3, 2026 at 1:28 am IST is closed at $0.9,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is 20/20 Biolabs, Inc. Common Stock's market capitalisation today?

20/20 Biolabs, Inc. Common Stock market capitalisation is $0.00T as on June 3, 2026 at 1:28 am IST.

How to invest in 20/20 Biolabs, Inc. Common Stock Stock (AIDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 20/20 Biolabs, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 20/20 Biolabs, Inc. Common Stock Shares that will get you 1.6667 shares as per 20/20 Biolabs, Inc. Common Stock share price of $0.9 per share as on June 3, 2026 at 1:28 am IST.

What is the minimum amount required to buy 20/20 Biolabs, Inc. Common Stock Stock (AIDX) from India?

Indian investors can start investing in 20/20 Biolabs, Inc. Common Stock (AIDX) shares with as little as ₹95.265 or $1 (as of June 3, 2026 at 5:58 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.65 in 20/20 Biolabs, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on June 3, 2026 at 5:58 am IST). Based on 20/20 Biolabs, Inc. Common Stock share’s latest price of $0.9 as on June 3, 2026 at 1:28 am IST, you will get 11.1111 shares of 20/20 Biolabs, Inc. Common Stock. Learn more about fractional shares .